Patents by Inventor Jun Okuda

Jun Okuda has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6475091
    Abstract: A power transmission device comprises a propeller shaft (PS) and a rear axle device (AR) that is linked and transmits rotational drive force. In the structure linking the propeller shaft and the rear axle device, a first mark indicating the direction of rotational imbalance in the propeller shaft is provided to the propeller shaft, a second mark is provided to a companion flange (30) linked to the propeller shaft in the rotation transmission device, for indicating the direction of rotational imbalance in the companion flange (30), and the propeller shaft and the companion flange are linked on the basis of the first and second marks.
    Type: Grant
    Filed: October 3, 2000
    Date of Patent: November 5, 2002
    Assignee: Honda Giken Kogyo Kabushiki Kaisha
    Inventors: Yasushi Sugiura, Takeshi Hori, Tooru Iiizumi, Toshiyuki Hosokawa, Jun Okuda
  • Patent number: 6291655
    Abstract: In binuclear metal hydride complexes of the formuula (I) the substituents and indices have the following meanings: M is scandium, yttrium, lanthanum or a lanthanide metal, R is hydrogen, halogen, C1-C20-alkyl, C3-C1-cycloalkyl, C6-C15-aryl or C3-C30-organosilyl, where two adjacent radicals R can also form a saturated or unsaturated, cyclic or heterocyclic group having from 4 to 18 carbon atoms, Z is —SiR′2—, —CR′2—, —GeR′2—, —SnR′2—, —BR′— or —O—, R′ is C1-C20-alkyl, C3-C10-cycloalkyl, C6-C15-aryl or alkylaryl having from 1 to 10 carbon atoms in the alkyl part and from 6 to 10 carbon atoms in the aryl part, m is 1 or 2, X is —O—, —S—, —NR″—, —PR″—, —OR″, —SR″, —NR″2 or —PR″2, R″ is hydrogen, C1-C20-alkyl, C3-C10-cycloalkyl, C6-C15-aryl, alkylaryl having from 1 to 10
    Type: Grant
    Filed: August 12, 1999
    Date of Patent: September 18, 2001
    Assignee: BASF Aktiengesellschaft
    Inventors: Jun Okuda, Kai Hultzsch, Michael Geprägs
  • Patent number: 5919961
    Abstract: Chiral compounds of the formula I ##STR1## where the variables are as described in the specification.
    Type: Grant
    Filed: May 30, 1997
    Date of Patent: July 6, 1999
    Assignee: BASF Aktiengesellschaft
    Inventors: Rainer Sturmer, Jun Okuda, Kurt Ritter
  • Patent number: 5232936
    Abstract: The present invention relates to novel hydantoin derivatives, processes for producing said hydantoin derivatives, pharmaceutical compositions containing at least one of said hydantoin derivatives as aldose reductase inhibitors and novel intermediate compounds in the synthesis of said hydantoin derivatives.The present invention is based on the selection of a hydantoin which is bonded by a sulfonyl group to various substituents at the 1-position of the hydantoin skeleton.The compounds of the present invention have a strong inhibitory activity against aldose reductase. These compounds are extremely useful for the treatment and/or prevention of various forms of diabetic complications based on the accumulation of polyol metabolites.
    Type: Grant
    Filed: January 23, 1991
    Date of Patent: August 3, 1993
    Assignee: Mochida Pharmaceutical Co., Ltd.
    Inventors: Ei Mochida, Kimihiro Murakami, Kazuo Kato, Katsuaki Kato, Jun Okuda, Ichitomo Miwa
  • Patent number: 5202339
    Abstract: The present invention relates to novel hydantoin derivatives, processes for producing said hydantoin derivatives, pharmaceutical compositions containing at least one of said hydantoin derivatives as aldose reductase inhibitors and novel intermediate compounds in the synthesis of said hydantoin derivatives and pharmaceutical compositions containing at least one of hydantoin derivatives as hypoglycemic as well as hypolipidemic agents.The present invention is based on the selection of a hydantoin which is bonded by a sulfonyl group to various substituents at the 1-position of the hydantoin skeleton. The compounds of the present invention have a strong inhibitory activity against aldose reductase. These compounds are extremely useful for the treatment and/or prevention of various forms of diabetic complications based on the accumulation of polyol metabolites.The compounds of the present invention represent a satisfactory hypoglycemic as well as hypolipidemic activity.
    Type: Grant
    Filed: February 25, 1991
    Date of Patent: April 13, 1993
    Assignee: Mochida Pharmaceutical Co., Ltd.
    Inventors: Ei Mochida, Kimihiro Murakami, Kazuo Kato, Katsuaki Kato, Jun Okuda, Ichitomo Miwa
  • Patent number: 5004751
    Abstract: The present invention relates to novel hydantoin derivatives, processes for producing said hydantoin derivatives, pharmaceutical compositions containing at least one of said hydantoin derivatives as aldose reductase inhibitors and novel intermediate compounds in the synthesis of said hydantoin derivatives.The present invention is based on the selection of a hydantoin which is bonded by a sulfonyl group to various substituents at the 1-position of the hydantoin skeleton.The compounds of the present invention have a strong inhibitory activity against aldose reductase. These compounds are extremely useful for the treatment and/or prevention of various forms of diabetic complications based on the accumulation of polyol metabolites.
    Type: Grant
    Filed: October 24, 1989
    Date of Patent: April 2, 1991
    Assignee: Mochida Pharmaceutical Co., Ltd.
    Inventors: Ei Mochida, Kimihiro Murakami, Kazuo Kato, Katsuaki Kato, Jun Okuda, Ichitomo Miwa
  • Patent number: 4914099
    Abstract: The present invention relates to novel hydantoin derivatives, processes for producing said hydantoin derivatives, pharmaceutical compositions containing at least one of said hydantoin derivatives as aldose reductase inhibitors and novel intermediate compounds in the synthesis of said hydantoin derivatives.The present invention is based on the selection of a hydantoin which is bonded by a sulfonyl group to various substituents at the 1-position of the hydantoin skeleton.
    Type: Grant
    Filed: August 24, 1988
    Date of Patent: April 3, 1990
    Assignee: Mochida Pharmaceutical Co., Ltd.
    Inventors: Ei Mochida, Kazuo Kato, Katsuaki Kato, Ichitomo Miwa, Jun Okuda
  • Patent number: 4728602
    Abstract: A light-sensitive silver iodobromide emulsion containing core/shell silver iodobromide grains having a core substantially comprising silver iodobromide containing at least about 5 mol % of silver iodide and a shell selected from the group consisting of (a) a shell comprising silver iodobromide having a lower silver iodide content than that of the silver iodobromide of the core and (b) a shell comprising silver bromide, wherein the relative standard deviation of the silver iodide content of the individual grains of said silver halide emulsion is lower than about 20%.
    Type: Grant
    Filed: October 7, 1986
    Date of Patent: March 1, 1988
    Assignee: Fuji Photo Film Co., Ltd.
    Inventors: Yoshihiko Shibahara, Shingo Ishimaru, Jun Okuda
  • Patent number: 4532254
    Abstract: An inhibitor of aldose reductase which contains, as the effective ingredient, a flavone derivative having the following formula: ##STR1## wherein R.sub.1 is hydrogen atom or hydroxyl group, R.sub.2 is hydroxyl group or methoxyl group or a pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable carrier. The inhibitor is useful for preventing, reducing or treating complications of diabetes.
    Type: Grant
    Filed: March 17, 1983
    Date of Patent: July 30, 1985
    Assignee: Kaken Pharmaceutical Co., Ltd.
    Inventors: Jun Okuda, Ichitomo Miwa, Kazuhiro Inagaki, Tokunaru Horie, Mitsuru Nakayama
  • Patent number: RE35279
    Abstract: The present invention relates to novel hydantoin derivatives, processes for producing said hydantoin derivatives, pharmaceutical compositions containing at least one of said hydantoin derivatives as aldose reductase inhibitors and novel intermediate compounds in the synthesis of said hydantoin derivatives.The present invention is based on the selection of a hydantoin which is bonded by a sulfonyl group to various substituents at the 1-position of the hydantoin skeleton.The compounds of the present invention have a strong inhibitory activity against aldose reductase. These compounds are extremely useful for the treatment and/or prevention of various forms of diabetic complications based on the accumulation of polyol metabolites.
    Type: Grant
    Filed: February 17, 1994
    Date of Patent: June 18, 1996
    Assignee: Mochida Pharmaceutical Co., Ltd.
    Inventors: Ei Mochida, Kimihiro Murakami, Kazuo Kato, Katsuaki Kato, Jun Okuda, Ichitomo Miwa